{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:40:31Z","timestamp":1792712431816,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-123490"],"award-info":[{"award-number":["MOP-123490"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Heart and Stroke Foundation of Canada"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.atherosclerosis.2014.09.008","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:37:00Z","timestamp":1410827820000},"page":"194-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Elsibucol inhibits atherosclerosis following arterial injury: Multifunctional effects on cholesterol levels, oxidative stress and inflammation"],"prefix":"10.1016","volume":"237","author":[{"given":"Sylvie","family":"Dussault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahiba","family":"Dhahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Desjarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0068-1515","authenticated-orcid":false,"given":"Raphael","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcin.2008.11.009","article-title":"Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress","volume":"2","author":"Pendyala","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib6","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2008.02.057","article-title":"Endothelial dysfunction associated with drug-eluting stents what, where, when, and how?","volume":"51","author":"Muhlestein","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2009.04.002","article-title":"Where are we with probucol: a new life for an old drug?","volume":"207","author":"Yamashita","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.CIR.88.2.628","article-title":"Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis","volume":"88","author":"Schneider","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0021-9150(95)05592-K","article-title":"Inhibitory effect of a single local probucol administration on neointimal formation in balloon-injured rat carotid artery","volume":"118","author":"Ishizaka","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0021-9150(92)90127-3","article-title":"Inhibition of intimal thickening of the carotid artery of rabbits and of outgrowth of explants of aorta by probucol","volume":"97","author":"Shinomiya","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0735-1097(01)01783-1","article-title":"Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST)","volume":"39","author":"Sawayama","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM199708073370601","article-title":"Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group","volume":"337","author":"Tardif","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib14","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archinte.1981.00340080138037","article-title":"QT-interval prolongation produced by probucol","volume":"141","author":"Klein","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib15","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1097\/01.TP.0000123076.05313.9F","article-title":"Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis","volume":"77","author":"Murata","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib16","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/S0960-894X(02)00516-4","article-title":"Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis","volume":"12","author":"Meng","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.0000050652.47145.4C","article-title":"Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor","volume":"107","author":"Gennaro","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0008-6363(99)00385-5","article-title":"Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis","volume":"45","author":"Rivard","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11886-012-0285-7","article-title":"Regression of atherosclerosis","volume":"14","author":"Arsenault","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2014.02.007","article-title":"A\u00a0systematic review of the time course of atherosclerotic plaque regression","volume":"234","author":"Noyes","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0735-1097(97)00270-2","article-title":"Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial","volume":"30","author":"Yokoi","year":"1997","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.CIR.97.5.429","article-title":"Prevention of restenosis after angioplasty in small coronary arteries with probucol","volume":"97","author":"Rodes","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib23","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(08)60763-1","article-title":"Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Tardif","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib24","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/01.CIR.0000066282.05411.17","article-title":"Pilot trial of oral rapamycin for recalcitrant restenosis","volume":"107","author":"Brara","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib25","first-page":"1386","article-title":"Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study","volume":"44","author":"Waksman","year":"2004","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib26","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jacc.2005.12.052","article-title":"Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study","volume":"47","author":"Rodriguez","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.09.008_bib28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501401404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501401404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T16:29:11Z","timestamp":1538238551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501401404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S002191501401404X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.008","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elsibucol inhibits atherosclerosis following arterial injury: Multifunctional effects on cholesterol levels, oxidative stress and inflammation","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}